EverPoint Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

EverPoint Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-435,585	Closed	-$2.09M	–	639
2015 Q4	$2.09M	Sell	435,585 -2,300,000	-84%	-$13M	0.04%	377
2015 Q3	$15.2M	Buy	2,735,585 +385,585	+16%	+$2.85M	0.39%	63
2015 Q2	$18.7M	Buy	2,350,000 +1,850,000	+370%	+$15.9M	0.34%	79
2015 Q1	$5.25M	Buy	+500,000	New	+$6.83M	0.1%	266

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EverPoint Asset Management's BDSI Position: Q1 2016 in Review

EverPoint Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2016, closing a stake of 435,585 shares — an estimated $2.09M sold.

EverPoint Asset Management first reported a position in BDSI in Q1 2015 and held it in 4 quarters. The position peaked at $18.7M in Q2 2015. 105 funds tracked by Wall St. Rank hold BDSI as of Q1 2016.

EverPoint Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2016 after selling out during the quarter.
EverPoint Asset Management sold 435,585 BioDelivery Sciences International, Inc. shares in Q1 2016, an estimated $2.09M.
EverPoint Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 4 quarters.
EverPoint Asset Management's BioDelivery Sciences International, Inc. position peaked at $18.7M in Q2 2015.
105 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.